Showing 21 - 40 results of 41 for search '"ESMO Open"', query time: 0.24s Refine Results
  1. 21
    In the literature: August 2018

    In the literature: August 2018 by Juan-Miguel Cejalvo, Gema Bruixola, Federica Papaccio

    Published 2019-07-01
    “…ESMO Open…”
    Get full text
    Article
  2. 22
    In the literature: April 2019

    In the literature: April 2019 by Gema Bruxiola, Juan-Miguel Cejalvo, Valentina Gambardella, Andrés Cervantes

    Published 2019-04-01
    “…ESMO Open…”
    Get full text
    Article
  3. 23
    Interim analysis of a real-world precision medicine platform for molecular profiling of metastatic or advanced cancers: MONDTI

    Interim analysis of a real-world precision medicine platform for molecular profiling of metastatic or advanced cancers: MONDTI by Christoph C Zielinski, Markus Kieler, Matthias Unseld, Daniela Bianconi, Fredrik Waneck, Robert Mader, Fritz Wrba, Thorsten Fuereder, Philipp Staber, Walter Berger, Maria Sibilia, Stephan Polterauer, Leonhard Müllauer, Gerald W Prager

    Published 2019-07-01
    “…ESMO Open…”
    Get full text
    Article
  4. 24
    Immune checkpoint inhibitor treatment in patients with oncogene-addicted non-small cell lung cancer (NSCLC): summary of a multidisciplinary round-table discussion

    Immune checkpoint inhibitor treatment in patients with oncogene-addicted non-small cell lung cancer (NSCLC): summary of a multidisciplinary round-table discussion by Nicola Normanno, Matthias Preusser, Julien Mazières, Anna S. Berghoff, Beatriz Bellosillo, Christophe Caux, Adrianus de Langen, Mariano Provencio, Federico Rojo, Jurgen Wolf

    Published 2019-06-01
    “…ESMO Open…”
    Get full text
    Article
  5. 25
    Phase II trial of ribociclib and letrozole in patients with relapsed oestrogen receptor-positive ovarian or endometrial cancers

    Phase II trial of ribociclib and letrozole in patients with relapsed oestrogen receptor-positive ovarian or endometrial cancers by Gretchen E Glaser, Gerardo Colon-Otero, Valentina Zanfagnin, Xiaonan Hou, Nathan R Foster, Erik J Asmus, Andrea Wahner Hendrickson, Aminah Jatoi, Matthew S Block, Carrie L Langstraat, Tri A Dinh, Matthew W Robertson, John K Camoriano, Kristina A Butler, John A Copland, S John Weroha

    Published 2020-10-01
    “…ESMO Open…”
    Get full text
    Article
  6. 26
    Completion rate and impact on physician–patient relationship of video consultations in medical oncology: a randomised controlled open-label trial

    Completion rate and impact on physician–patient relationship of video consultations in medical oncology: a randomised controlled open-label trial by Andreas Schneeweiss, Erkin Erdal, Leon Mühlsteffen, Hans Martin Singh, Editha Gnutzmann, Barbara Grün, Helene Hofmann, Alexandra Ivanova, Bruno Christian Köhler, Felix Korell, Athanasios Mavratzas, David Schult, Niels Steinebrunner, Johannes Krisam, Jakob N Kather

    Published 2020-12-01
    “…ESMO Open…”
    Get full text
    Article
  7. 27
    Improved efficacy of taxanes and ramucirumab combination chemotherapy after exposure to anti-PD-1 therapy in advanced gastric cancer

    Improved efficacy of taxanes and ramucirumab combination chemotherapy after exposure to anti-PD-1 therapy in advanced gastric cancer by Saori Mishima, Akihito Kawazoe, Yasutoshi Kuboki, Takashi Kojima, Toshihiko Doi, Takayuki Yoshino, Kohei Shitara, Yoshiaki Nakamura, Kentaro Sawada, Hiroya Taniguchi, Daisuke Kotani, Akinori Sasaki, Testuya Eto, Mashiro Okunaka, Tetsuo Akimoto

    Published 2020-10-01
    “…ESMO Open…”
    Get full text
    Article
  8. 28
    Endocrine therapy-based treatments in hormone receptor-positive/HER2-negative advanced breast cancer: systematic review and network meta-analysis

    Endocrine therapy-based treatments in hormone receptor-positive/HER2-negative advanced breast cancer: systematic review and network meta-analysis by Matteo Lambertini, Mariana Brandão, Evandro de Azambuja, Christian Maurer, Patricia Klarmann Ziegelmann, Noam F Pondé, Arlindo Ferreira, Samuel Martel, Martine Piccart, Márcio Debiasi

    Published 2020-10-01
    “…ESMO Open…”
    Get full text
    Article
  9. 29
    Impact of tumour growth rate during preceding treatment on tumour response to regorafenib or trifluridine/tipiracil in refractory metastatic colorectal cancer

    Impact of tumour growth rate during preceding treatment on tumour response to regorafenib or trifluridine/tipiracil in refractory metastatic colorectal cancer by Toshiki Masuishi, Hiroya Taniguchi, Yoshito Komatsu, Takeshi Kawakami, Yasuyuki Kawamoto, Shigenori Kadowaki, Yusuke Onozawa, Tetsuhito Muranaka, Masahiro Tajika, Hirofumi Yasui, Hiroshi Nakatsumi, Satoshi Yuki, Kei Muro, Katsuhiro Omae, Kentaro Yamazaki

    Published 2019-11-01
    “…ESMO Open…”
    Get full text
    Article
  10. 30
    Chemotherapy plus bevacizumab as an optimal first-line therapeutic treatment for patients with right-sided metastatic colon cancer: a meta-analysis of first-line clinical trials

    Chemotherapy plus bevacizumab as an optimal first-line therapeutic treatment for patients with right-sided metastatic colon cancer: a meta-analysis of first-line clinical trials by Xia-Hong You, Yu-Huan Jiang, Zhou Fang, Yao Li, Zi-Jin Xia, Xiao-Zhong Wang, Hou-Qun Ying

    Published 2019-05-01
    “…ESMO Open…”
    Get full text
    Article
  11. 31
    Can multigene assays widen their clinical usefulness in early breast cancer treatment choice during the current COVID-19 outbreak in Italy?

    Can multigene assays widen their clinical usefulness in early breast cancer treatment choice during the current COVID-19 outbreak in Italy? by Alberto Zambelli, Carlo Alberto Tondini

    Published 2020-11-01
    “…ESMO Open…”
    Get full text
    Article
  12. 32
    Metastatic breast cancer and pseudocirrhosis: an unknown clinical entity

    Metastatic breast cancer and pseudocirrhosis: an unknown clinical entity by Michel Moreau, Ahmad Awada, Marianne Paesmans, Dan Engelman, Antonia Lepida, Yasmine Zaouak

    Published 2020-05-01
    “…ESMO Open…”
    Get full text
    Article
  13. 33
    Young patients with cancer and a digital social network: the voice beyond the clinic

    Young patients with cancer and a digital social network: the voice beyond the clinic by Elisa Fontana, Florian Lordick, Irit Ben-Aharon, Tal Goshen-Lago, Ilit Turgeman, Elizabeth Smyth

    Published 2020-05-01
    “…ESMO Open…”
    Get full text
    Article
  14. 34
    HER2-targeted therapy should be shifted towards an earlier line for patients with anti-EGFR-therapy naïve, HER2-amplified metastatic colorectal cancer

    HER2-targeted therapy should be shifted towards an earlier line for patients with anti-EGFR-therapy naïve, HER2-amplified metastatic colorectal cancer by Takayuki Yoshino, Yoshiaki Nakamura, Kentaro Sawada, Satoshi Fujii

    Published 2019-06-01
    “…ESMO Open…”
    Get full text
    Article
  15. 35
    Validation of prognostic scoring systems for patients with metastatic renal cell carcinoma enrolled in phase I clinical trials

    Validation of prognostic scoring systems for patients with metastatic renal cell carcinoma enrolled in phase I clinical trials by Pavlos Msaouel, Nizar M. Tannir, Eric Jonasch, Hung Le, Andrew W Hahn, Omar Alhalabi, Erick Campbell

    Published 2020-12-01
    “…ESMO Open…”
    Get full text
    Article
  16. 36
    MiR-100 is a predictor of endocrine responsiveness and prognosis in patients with operable luminal breast cancer

    MiR-100 is a predictor of endocrine responsiveness and prognosis in patients with operable luminal breast cancer by Danilo Galizia, Anna Sapino, Filippo Montemurro, Elena Geuna, Annalisa Petrelli, Sara Erika Bellomo, Ivana Sarotto, Franziska Kubatzki, Paola Sgandurra, Furio Maggiorotto, Maria Rosaria Di Virgilio, Riccardo Ponzone, Anna Maria Nuzzo, Enzo Medico, Umberto Miglio, Enrico Berrino, Tiziana Venesio, Salvatore Ribisi, Paolo Provero, Silvia Giordano

    Published 2020-10-01
    “…ESMO Open…”
    Get full text
    Article
  17. 37
    Rechallenge of denosumab in jaw osteonecrosis of patients with unresectable giant cell tumour of bone: a case series analysis and literature review

    Rechallenge of denosumab in jaw osteonecrosis of patients with unresectable giant cell tumour of bone: a case series analysis and literature review by Alessandra Raimondi, Silvia Stacchiotti, Paolo G Casali, Noemi Simeone, Marco Guzzo, Massimo Maniezzo, Paola Collini, Carlo Morosi, Francesca Gabriella Greco, Anna Maria Frezza

    Published 2020-10-01
    “…ESMO Open…”
    Get full text
    Article
  18. 38
    Breast cancer subtypes: implications for the treatment and survival of patients in Africa—a prospective cohort study from Mozambique

    Breast cancer subtypes: implications for the treatment and survival of patients in Africa—a prospective cohort study from Mozambique by Mariana Brandão, Cesaltina Lorenzoni, Nuno Lunet, Fernando Schmitt, Assucena Guisseve, Genoveva Bata, Matos Alberto, Josefo Ferro, Carlos Garcia, Clésio Zaqueu, Dina Leitão, Jotamo Come, Otília Soares, Alberto Gudo-Morais, Satish Tulsidás, Carla Carrilho

    Published 2020-10-01
    “…ESMO Open…”
    Get full text
    Article
  19. 39
    Olaratumab administered in two cases of phyllodes tumour of the breast: end of the beginning?

    Olaratumab administered in two cases of phyllodes tumour of the breast: end of the beginning? by Anastasios Kyriazoglou, Flora Zagouri, Meletios A Dimopoulos

    Published 2019-06-01
    “…ESMO Open…”
    Get full text
    Article
  20. 40
    In the literature: June 2019

    In the literature: June 2019 by Juan-Miguel Cejalvo, Valentina Gambardella, Andrés Cervantes, Tania Fleitas-Kanonnikoff, Angela Lamarca

    Published 2019-06-01
    “…ESMO Open…”
    Get full text
    Article

Search Tools: